Results for
""Naltrexone""[mesh_terms]

Changes in lipid profile and glucose metabolism following administration of bupropion alone or in combination with naltrexone: A systematic review and meta-regression analysis.

Periyannan Velu, Pejman Rohani, Mohammad Hassan Sohouli, Yi Hu

European journal of clinical investigation 2024;54(4):e14122

Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date.

Assumpta Caixàs, Lara Albert, Ismael Capel, Mercedes Rigla

Drug design, development and therapy 2015;8():1419-27

Cutting-Edge Approaches to Obesity Management: The Latest Pharmacological Options.

Katherine H Saunders, Louis J Aronne, Sarah H Schmitz

Endocrinology and metabolism clinics of North America 2025;54(1):85-102

Pharmacological management of gambling disorder: an update of the literature.

Gemma Mestre-Bach, Marc N Potenza

Expert review of neurotherapeutics 2024;24(4):391-407

A systematic review of licensed weight-loss medications in treating antipsychotic-induced weight gain and obesity in schizophrenia and psychosis.

Kenn Lee, Seri Abraham, Robert Cleaver

General hospital psychiatry 2022;78():58-67

The current situation of treatment systems for alcoholism in Korea.

Jee Wook Kim, Boung Chul Lee, Tae-Cheon Kang, Ihn-Geun Choi

Journal of Korean medical science 2013;28(2):181-9

An open-label trial on the efficacy and tolerability of naltrexone/bupropion SR for treating altered eating behaviours and weight loss in binge eating disorder.

Elvira Anna Carbone, Mariarita Caroleo, Marianna Rania, Giuseppina Calabrò, Filippo Antonio Staltari, Renato de Filippis, Matteo Aloi, Francesca Condoleo, Franco Arturi, Cristina Segura-Garcia

Eating and weight disorders : EWD 2021;26(3):779-788

Repurposing drugs for treatment of alcohol use disorder.

Henri-Jean Aubin

International review of neurobiology 2024;175():153-185

New treatment modalities for obesity.

E Miraglia Del Giudice, A Grandone, A Di Sessa, G R Umano, R Toraldo

Best practice & research. Clinical endocrinology & metabolism 2018;32(4):535-549

Obesity Pharmacotherapy.

Katherine H Saunders, Devika Umashanker, Leon I Igel, Rekha B Kumar, Louis J Aronne

The Medical clinics of North America 2017;102(1):135-148

New-generation anti-obesity drugs: naltrexone/bupropion and liraglutide. An update for endocrinologists and nutritionists.

Silvia Savastano, Luigi Barrea, Gabriella Pugliese, Giovanna Muscogiuri, Daniela Laudisio, Annamaria Colao

Minerva endocrinologica 2021;45(2):127-137

The efficacy and safety of the naltrexone/bupropion combination for the treatment of obesity: an update.

Georgios A Christou, Dimitrios N Kiortsis

Hormones (Athens, Greece) 2016;14(3):370-5

The effects of bupropion alone and combined with naltrexone on blood pressure and CRP concentration: A systematic review and meta-regression analysis of randomized controlled trials.

Periyannan Velu, Mohammad Hassan Sohouli, Qidong Jiang, Fateme Ziamanesh, Shima Shojaie, Somaye Fatahi, Qin Li

European journal of clinical investigation 2024;54(3):e14118

Association of long-term weight management pharmacotherapy with multiple health outcomes: an umbrella review and evidence map.

Ya-Li Liu, Yu Lu, Ting-Ting Lu, Long Ge, Bin Liu

International journal of obesity (2005) 2025;49(3):464-477

Naltrexone/bupropion for obesity.

Drug and therapeutics bulletin 2018;55(11):126-129